Key result
A multisite quality improvement collaboration significantly improved process-of-care indicators, including increased use of therapeutic heparin for ACS (84% vs 72%; P<0.001).
Why the study?
Does a multisite quality-improvement collaboration improve process-of-care indicators and clinical outcomes in patients admitted with ACS or CHF?
Does a multisite quality-improvement collaboration improve process-of-care indicators and clinical outcomes in patients admitted with ACS or CHF?
Absolute Event Rate: 84% vs 72%
p-value: p=<0.001
A multisite quality-improvement collaboration significantly improved adherence to guideline-directed medical therapies and reduced 30-day readmissions for patients hospitalized with ACS and CHF.
No takes yet. Share an insight, caveat, or question.
Quality improvement collaboration was associated with better ACS process measures; leaves open effects on outcomes and broader adoption.
Scott et al. (2004) studied Acute coronary syndromes (ACS) or congestive heart failure (CHF) (n=2,101). Multisite quality improvement collaboration vs. Baseline period (standard care) was evaluated on Changes in process-of-care indicators (e.g., therapeutic heparin regimens for ACS) (p=<0.001). A multisite quality improvement collaboration significantly improved process-of-care indicators, including increased use of therapeutic heparin for ACS (84% vs 72%; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: